Can-Fite expands its Namodenoson Distribution Deal with CKD
Korea | News | 0 Comment | 27 Feb, 2019
Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer...Read more
ABL Bio, WuXi Bio expand strategic collaboration for $220M
Korea | News | 0 Comment | 26 Feb, 2019
WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...Read more
Xynomic Pharma doses first South Korean patient in Phase 3 RCC trial
Korea | News | 0 Comment | 25 Feb, 2019
Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp.jointly ...Read more
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study
Korea | News | 0 Comment | 22 Feb, 2019
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...Read more
Korean govt to inject $2.6B to develop biotech in 2019
Korea | News | 0 Comment | 20 Feb, 2019
According to reports from the Korean Herald, the government of Korea will spend 2.93 trillion won (US$2.61 billion...Read more
ROKIT brings innovative 3D bioprinting strategy for skin regeneration
Korea | News | 0 Comment | 20 Feb, 2019
ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic str...Read more
SK Biopharma to take antiepileptic drug to Europe
Korea | News | 0 Comment | 18 Feb, 2019
SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing ag...Read more
Bridge Bio presents Preclinical, Ph I study results for BBT-401
Korea | News | 0 Comment | 12 Feb, 2019
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the...Read more
OliX announces clinical candidate for Geographic Atrophy treatment
Korea | News | 0 Comment | 29 Jan, 2019
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...Read more
US FDA approves Samsung Bioepis' first oncology drug
Korea | News | 0 Comment | 21 Jan, 2019
Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencin...Read more
Bridge Bio receives FDA ODD for IPF drug
Korea | News | 0 Comment | 17 Jan, 2019
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...Read more
Glenmark enters commercialization agreement with Yuhan Corp
Korea | News | 0 Comment | 10 Jan, 2019
Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, has announced that its Suisse su...Read more
Norgine, Korea Pharma ink deal to commercialise PLENVU in Korea
Korea | News | 0 Comment | 08 Jan, 2019
NORGINE B.V. (Norgine), a leading European specialty pharmaceutical company and KOREA PHARMA CO., LTD. (Korea Pharma), a...Read more
Gilead Sciences, Yuhan to treat advanced fibrosis due to NASH
Korea | News | 0 Comment | 07 Jan, 2019
Gilead Sciences, Inc. and Yuhan Corporation has announced that the companies have entered into a licensing and collabora...Read more
South Korea IVD Market 2017-2022; overview by ResearchAndMarkets
Korea | News | 0 Comment | 02 Jan, 2019
South Korea is the 27th largest country worldwide with 51.2 million people as of 2017. In their healthcare market, ...Read more
Bridge Bio announces activation of clinical trial sites for Phase 2 study of UC drug candidate
Korea | News | 0 Comment | 28 Dec, 2018
Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...Read more
Eventi Telematici, Penta Security strengthens partnership for DataBreast
Korea | News | 0 Comment | 20 Dec, 2018
In recent years, several regulatory laws enforcing data privacy – that requires organizations to strengthen data p...Read more
Bridge Bio signs $40M license agreement with Daewoong Pharma
Korea | News | 0 Comment | 19 Dec, 2018
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...Read more